Beta Bionics, Inc. Common Stock BBNX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$21.9M-62.6% | -$13.47M+5.2% | -$14.21M+15.8% | -$16.87M+41.1% | -$28.66M-58.3% | ||
| $585K+8.7% | $538K+39.7% | $385K+11.0% | $347K+14.5% | $303K+30.6% | ||
| $5.41M+25.6% | $4.3M-3.9% | $4.48M-6.7% | $4.8M+71.1% | $2.8M+80.7% | ||
| -$23.83M-176% | -$8.63M+1.2% | -$8.73M+35.8% | -$13.59M+31.9% | -$19.98M-39.9% | ||
| $1.38M-27.6% | $1.9M+48.4% | $1.28M-27.9% | $1.78M+434% | $333K-40.6% | ||
| $21.84M— | —— | —— | —— | -$179.12M-504% | ||
| $623K-41.2% | $1.06M-60.0% | $2.65M+6,217% | $42K-100.0% | $211.12M+271% | ||
| -$1.37M— | —— | $3.41M— | —— | $12.02M-7.2% | ||
| -$25.21M-139% | -$10.53M-5.2% | -$10.01M+34.9% | -$15.37M+24.3% | -$20.31M-36.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beta Bionics, Inc. Common Stock generate?
- Beta Bionics, Inc. Common Stock (BBNX) generated -$54.8M in operating cash flow over the trailing twelve months.
- What is Beta Bionics, Inc. Common Stock's free cash flow?
- After $6.3M of capital expenditures, Beta Bionics, Inc. Common Stock's free cash flow was -$61.1M over the trailing twelve months, down 2.9% year over year.
- Where does Beta Bionics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
